FDA Acceptance of Two Synerx Pharma ANDAs
10/19/2005 5:09:22 PM
NEWTOWN, Pa.--(BUSINESS WIRE)--June 28, 2005--Synerx Pharma, LLC announces the FDA acceptance of its first two Abbreviated New Drug Applications. These products were developed by Synerx Pharma during the second half of 2004 and filed with the FDA in January and February of 2005. Synerx Pharma currently has ten products in various stages of development.
The development efforts encompass four different dosage form categories and five exclusive API (Active Pharmaceutical Ingredients) agreements with multiple manufacturers. The company intends to maintain an aggressive development program for products addressing underserved generic markets.
comments powered by